Improvement of mortality prognostication in patients with epidermal necrolysis: The role of novel inflammatory markers and proposed revision of SCORTEN (Re-SCORTEN)
JAMA Jan 05, 2022
Koh HK, Fook-Chong SMC, Lee HY, et al. - Researchers investigated the utility of novel inflammatory markers such as red cell distribution width to hemoglobin ratio (RDW/Hb) in prognostication of mortality in patients with epidermal necrolysis.
A retrospective cohort study of 192 patients was conducted over a 17-year period in an Asian reference center.
There appeared a strong predictive value of RDW/Hb for in-hospital mortality and bacteremia.
RDW/Hb showed similar discrimination to the Severity-of-Illness Score for Toxic Epidermal Necrolysis (SCORTEN), which is the most commonly used prognostic score in epidermal necrolysis.
Addition of RDW/Hb to SCORTEN resulted in improvement of the predictive accuracy of the composite score (Re-SCORTEN).
Overall findings support the utility of measuring RDW/Hb in addition to SCORTEN in improving the mortality prognostication of epidermal necrolysis.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries